CA2480184A1 - The use of a 3895 bp mitochondrial dna deletion as a marker for sunlight exposure in human skin - Google Patents

The use of a 3895 bp mitochondrial dna deletion as a marker for sunlight exposure in human skin Download PDF

Info

Publication number
CA2480184A1
CA2480184A1 CA002480184A CA2480184A CA2480184A1 CA 2480184 A1 CA2480184 A1 CA 2480184A1 CA 002480184 A CA002480184 A CA 002480184A CA 2480184 A CA2480184 A CA 2480184A CA 2480184 A1 CA2480184 A1 CA 2480184A1
Authority
CA
Canada
Prior art keywords
deletion
mtdna
biological sample
subject
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002480184A
Other languages
French (fr)
Other versions
CA2480184C (en
Inventor
Mark Birch-Machin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MDNA LIFE SCIENCES Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA2480184A priority Critical patent/CA2480184C/en
Publication of CA2480184A1 publication Critical patent/CA2480184A1/en
Application granted granted Critical
Publication of CA2480184C publication Critical patent/CA2480184C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A method for detecting the genesis and progression of UV damage to the skin. This invention is related to the field of mitochondrial genomics. In particular it is related to deletions in the mitochondrial genome, in particular the 3895 by deletion of the minor arc. The deletion can be used as an indicator of the genesis and progression of UV damage to skin, for example skin cancer, and in particular non-melanoma skin cancer (NMSC).

Claims (18)

1. A method of detecting a deletion spanning approximately nucleotides 547 to in the minor arc of the mtDNA genome, wherein said deletion is associated with skin cancer and/or sun exposure, in a subject having mtDNA, comprising:
(a) providing a biological sample from sun exposed skin from the subject;
(b) extracting mtDNA from the biological sample; and (c) detecting the presence of the deletion in the mtDNA.
2. A method of monitoring a subject for the progression toward skin cancer, comprising:
(a) providing a biological sample from the subject;
(b) extracting mtDNA from the biological sample; and (c) detecting the absence or presence of 3895 by deletion.
3. A method for determining the cumulative UV exposure in a subject having mtDNA, comprising:
(a) providing a biological sample from the subject;
(b) extracting mtDNA from the biological sample; and (c) detecting the absence or presence of 3895 by deletion.
4. A method for an early detection for NMSC development, comprising:
(a) providing a biological sample from the subject;
(b) extracting mtDNA from the biological sample; and (c) detecting the absence or presence of 3895 by deletion.
5. A method for monitoring long term safety of clincial UV phototherapy regimes, comprising:
(a) providing a biological sample from the subject;

(b) extracting mtDNA from the biological sample; and (c) detecting the absence or presence of 3895 by deletion.
6. The method of any of claims 1 to 5 wherein the deletion is approximately bp.
7. The method of any of claims 1 to 5 wherein the deletion comprises a span of mtDNA from approximately mtTF1 binding site in the D-loop to tRNA methionine.
8. The method of any of claims 1 to 5 wherein the deletion includes substantially a 12s rRNA gene, a16s rRNA gene, a ND1 gene and promoters for transcription of H
and L strands.
9. The method of any of claims 1 to 5 wherein the step of detecting the presence of the deletion in the mtDNA comprises PCR analysis.
10. The method of claim 9 wherein the PCR analysis comprises radioactive PCR
analysis.
11. A nucleic acid primer L404 comprising CTT TTG GCG GTA TGC ACT TT.
12. A nucleic acid primer H4676 comprising GAT TAT GGA TGC GGT TGC TT.
13. The method of any of claims 1 to 5 wherein the biological sample is from a dermis layer of the subject.
14. The method of claim 13 wherein the biological sample is from rarely sun exposed, occasionally sun exposed, or usually sun exposed skin.
15. The method of claim 13 further comprising a step of comparing the absence or presence of 3895 deletion in rarely sun exposed, occasionally sun exposed, or usually sun exposed skin.
16. Use of a mtDNA deletion spanning approximately 547 to 4443 of the mtDNA
genome for detecting sun exposure and/or skin cancer.
17. Use of a mtDNA deletion spanning approximately 547 to 4443 of the mtDNA
genome as a biomarker for NMSC.
18. A method for the collection of a patient sample for use in diagnosing skin cancer by using a deletion spanning approximately nucleotides 547 to 4443 in the minor arc of the mtDNA genome, comprising:
(a) providing a biological sample from the subject.
CA2480184A 2004-10-14 2004-10-14 The use of a 3895 bp mitochondrial dna deletion as a marker for sunlight exposure in human skin Expired - Fee Related CA2480184C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2480184A CA2480184C (en) 2004-10-14 2004-10-14 The use of a 3895 bp mitochondrial dna deletion as a marker for sunlight exposure in human skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2480184A CA2480184C (en) 2004-10-14 2004-10-14 The use of a 3895 bp mitochondrial dna deletion as a marker for sunlight exposure in human skin

Publications (2)

Publication Number Publication Date
CA2480184A1 true CA2480184A1 (en) 2006-04-14
CA2480184C CA2480184C (en) 2011-12-20

Family

ID=36177374

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2480184A Expired - Fee Related CA2480184C (en) 2004-10-14 2004-10-14 The use of a 3895 bp mitochondrial dna deletion as a marker for sunlight exposure in human skin

Country Status (1)

Country Link
CA (1) CA2480184C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011106892A1 (en) * 2010-03-01 2011-09-09 Mitomics Inc. Uv associated mtdna fusion transcripts and methods and uses thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011106892A1 (en) * 2010-03-01 2011-09-09 Mitomics Inc. Uv associated mtdna fusion transcripts and methods and uses thereof
EP3305902A1 (en) 2010-03-01 2018-04-11 MDNA Life Sciences Inc. Uv associated mtdna fusion transcripts and methods and uses thereof

Also Published As

Publication number Publication date
CA2480184C (en) 2011-12-20

Similar Documents

Publication Publication Date Title
AU2010329552B2 (en) Categorization of DNA samples
JP2018514187A5 (en)
RU2720713C9 (en) Set of synthetic oligonucleotides for detecting of coronavirus rna
CN105358713B (en) Variants of TNFSF15 and DCR3 associated with Crohn's disease
CN103484533A (en) Method used for detecting HLA-B*5801 alleles
ATE431429T1 (en) METHOD AND NUCLEIC ACIDS FOR ANALYZING COLON CANCER CELLS
NZ584595A (en) Methods for assaying melanocortin 1 receptor variants utilysing a mitochondrial DNA abberration which is a 3895 bp mtDNA deletion between nucleic acid 546 to 4444 of the mtDNA genome
US20110306505A1 (en) X-STR multiplex PCR amplification system
WO2003052135A3 (en) Method and nucleic acids for the analysis of a lung cell proliferative disorder
Gomes et al. Validation of quantitative real-time PCR for the in vitro assessment of antileishmanial drug activity
WO2004020662A3 (en) Method and nucleic acids for the analysis of breast cell proliferative disorders
KR20110094041A (en) Gene sensitive to normal-tension glaucoma disease, and use thereof
CN102965427A (en) Establishment of female genital cancer relevant SNP sites multiple detection method
CA2480184A1 (en) The use of a 3895 bp mitochondrial dna deletion as a marker for sunlight exposure in human skin
McCord et al. Applications of epigenetic methylation in body fluid identification, age determination and phenotyping
Gavazaj et al. Optimization of DNA concentration to amplify short tandem repeats of human genomic DNA
Li et al. Pyrosequencing of a short fragment of the amelogenin gene for gender identification
Sullivan et al. Characterisation of HLA DQα for forensic purposes. Allele and genotype frequencies in British Caucasian, Afro-Caribbean and Asian populations
Qin et al. Genotyping the–6A/G functional polymorphism in the core promoter region of angiotensinogen gene by microchip electrophoresis
Żaczek et al. Genotyping of clinical Mycobacterium tuberculosis isolates based on IS6110 and MIRU-VNTR polymorphisms
WO2014009578A1 (en) Method for obtaining an individual's genetic profile by means of x chromosome loci analysis
EP1829978A4 (en) Method of detecting gene methylation and method of examining neoplasm by detecting methylation
WO2003078661A1 (en) Method and kit for detection of mutations in mitochondrial dna
KR102628993B1 (en) Portable LAMP-PCR device for POCT
Matsuda et al. Evaluation of various methods of DNA analysis for hair samples

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20201014